文献
J-GLOBAL ID:202002288924699121
整理番号:20A0783098
2型糖尿病の過体重または肥満中国人患者におけるインスリングラルギン100 U/MLのより高い対標準的な開始用量:多施設オープンラベル無作為化対照試験(VII)の結果【JST・京大機械翻訳】
Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open-label, randomized controlled trial (BEYOND VII)
著者 (15件):
Ji Linong
(Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing, China)
,
Wan Hailong
(Department of Endocrinology, Panjin Central Hospital, Panjin, China)
,
Wen Binhong
(Department of Endocrinology, People’s Hospital of Liaoning Province, Liaoning, China)
,
Wang Xueying
(Department of Endocrinology, Jinzhou Central Hospital, Jinzhou, China)
,
Wang Junfen
(Department of Endocrinology, Second Hospital of Shijiazhuang, Shijiazhuang, China)
,
Bian Rongwen
(Department of Endocrinology and Metabolism, Jiangsu Province Institute of Geriatrics, Nanjing, Jiangsu, China)
,
Pang Wuyan
(Department of Endocrinology and Metabolism, Huaihe Hospital of Henan University, Kaifeng, Henan, China)
,
Tian Jian
(Department of Endocrinology and Metabolism, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China)
,
Wang Yan
(Department of Endocrinology, Second Hospital of Chaoyang City, Chaoyang City, China)
,
Bian Fang
(Department of Endocrinology, Cangzhou People’s Hospital, Cangzhou, China)
,
Gao Zhengnan
(Department of Endocrinology and Metabolism, Dalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, Liaoning, China)
,
Condoleon Alex
(Sanofi, Paris, France)
,
Feng Wei
(Sanofi, Shanghai, China)
,
Zhang Xia
(Sanofi, Shanghai, China)
,
Cui Nan
(Sanofi, Shanghai, China)
資料名:
Diabetes Obesity & Metabolism
(Diabetes Obesity & Metabolism)
巻:
22
号:
5
ページ:
838-846
発行年:
2020年
JST資料番号:
W2549A
ISSN:
1462-8902
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)